Moderna has opened an mRNA facility in Oxfordshire (pictured), but many pharma companies are pulling out of the UK
Image: Moderna
14 October 2025FeaturesEuropeTim Belcher
As investment in UK life sciences wanes, is the sector in trouble?
As Big Pharma stalls investment in the UK, the government urgently needs to return to the negotiating table to salvage a key growth area, writes Tim Belcher of EIP.
